Novel Triple-dose Tuberculosis Retreatment Regimen

NCT04260477 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

370

Enrollment

OTHER

Sponsor class

Conditions

Multidrug-resistant Tuberculosis
Pulmonary Tuberculosis
Tuberculosis
Resistance to Tuberculostatic Drugs

Interventions

DRUG: 6EH³R³Z
DRUG: 6EHRZ

Sponsor

Institute of Tropical Medicine, Belgium

Collaborators

[object Object]